Twin Tree Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34M | Buy |
560,100
+317,000
| +130% | +$18.5M | 0.72% | 14 |
|
|
2025
Q4 | $13.1M | Buy |
+243,100
| New | +$11.7M | 0.11% | 220 |
|
|
2025
Q3 | – | Sell |
-176,200
| Closed | -$8.16M | – | 1474 |
|
|
2025
Q2 | $8.16M | Buy |
+176,200
| New | +$8.65M | 0.02% | 847 |
|
|
2024
Q4 | – | Sell |
-137,600
| Closed | -$7.12M | – | 1582 |
|
|
2024
Q3 | $7.12M | Buy |
+137,600
| New | +$6.45M | 0.01% | 782 |
|
|
2022
Q2 | – | Sell |
-568,700
| Closed | -$41.5M | – | 1504 |
|
|
2022
Q1 | $41.5M | Buy |
+568,700
| New | +$38.2M | 0.07% | 239 |
|
|
2021
Q1 | – | Sell |
-20,200
| Closed | -$1.25M | – | 1357 |
|
|
2020
Q4 | $1.25M | Sell |
20,200
-29,800
| -60% | -$1.83M | 0.01% | 937 |
|
|
2020
Q3 | $3.02M | Buy |
+50,000
| New | +$3.01M | 0.01% | 687 |
|
|
2020
Q1 | – | Sell |
-367,700
| Closed | -$23.6M | – | 1359 |
|
|
2019
Q4 | $23.6M | Sell |
367,700
-507,400
| -58% | -$29.1M | 0.08% | 194 |
|
|
2019
Q3 | $44.4M | Buy |
875,100
+8,300
| +1% | +$390K | 0.18% | 84 |
|
|
2019
Q2 | $39.3M | Buy |
866,800
+720,600
| +493% | +$33.6M | 0.19% | 98 |
|
|
2019
Q1 | $6.97M | Sell |
146,200
-375,800
| -72% | -$18.7M | 0.04% | 370 |
|
|
2018
Q4 | $27.1M | Buy |
522,000
+506,400
| +3,246% | +$27.2M | 0.17% | 108 |
|
|
2018
Q3 | $968K | Buy |
+15,600
| New | +$926K | 0.01% | 721 |
|
|
2017
Q4 | – | Sell |
-78,600
| Closed | -$5.01M | – | 1009 |
|
|
2017
Q3 | $5.01M | Sell |
78,600
-246,500
| -76% | -$14.4M | 0.04% | 373 |
|
|
2017
Q2 | $18.1M | Sell |
325,100
-464,300
| -59% | -$25.3M | 0.14% | 142 |
|
|
2017
Q1 | $42.9M | Buy |
789,400
+750,400
| +1,924% | +$41.2M | 0.39% | 46 |
|
|
2016
Q4 | $2.28M | Sell |
39,000
-40,000
| -51% | -$2.19M | 0.02% | 589 |
|
|
2016
Q3 | $4.26M | Buy |
79,000
+36,300
| +85% | +$2.33M | 0.05% | 320 |
|
|
2016
Q2 | $3.14M | Sell |
42,700
-56,100
| -57% | -$3.96M | 0.05% | 368 |
|
|
2016
Q1 | $6.31M | Buy |
98,800
+56,500
| +134% | +$3.56M | 0.12% | 185 |
|
|
2015
Q4 | $2.91M | Buy |
42,300
+37,300
| +746% | +$2.46M | 0.06% | 314 |
|
|
2015
Q3 | $296K | Sell |
5,000
-98,100
| -95% | -$6.22M | 0.01% | 905 |
|
|
2015
Q2 | $6.86M | Buy |
103,100
+89,100
| +636% | +$5.87M | 0.17% | 120 |
|
|
2015
Q1 | $903K | Buy |
14,000
+1,800
| +15% | +$113K | 0.02% | 620 |
|
|
2014
Q4 | $720K | Buy |
+12,200
| New | +$688K | 0.02% | 691 |
|
|
2014
Q3 | – | Sell |
-330,500
| Closed | -$16M | – | 992 |
|
|
2014
Q2 | $16M | Buy |
330,500
+72,000
| +28% | +$3.55M | 0.36% | 34 |
|
|
2014
Q1 | $13.4M | Buy |
258,500
+221,100
| +591% | +$11.8M | 0.27% | 42 |
|
|
2013
Q4 | $1.99M | Sell |
37,400
-64,500
| -63% | -$3.29M | 0.05% | 402 |
|
|
2013
Q3 | $4.72M | Sell |
101,900
-26,600
| -21% | -$1.17M | 0.16% | 128 |
|
|
2013
Q2 | $5.74M | Buy |
+128,500
| New | +$5.58M | 0.22% | 65 |
|
Other funds holding BMY
VCM
VPM
Twin Tree Management's BMY Position: Q1 2026 in Review
Twin Tree Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 356,621 shares — an estimated $20.8M sold.
Twin Tree Management first reported a position in BMY in Q4 2013 and held it in 34 quarters. The position peaked at $24.3M in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Twin Tree Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Twin Tree Management sold 356,621 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8M.
- Twin Tree Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 34 quarters.
- Twin Tree Management's Bristol-Myers Squibb position peaked at $24.3M in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.